Results 41 to 50 of about 13,648 (298)
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach [PDF]
, 2016 Ulcerative colitis (UC) is an immune-mediated disease of the colon that is characterized by diffuse and continuous inflammation contiguous from the rectum. Half of UC patients have inflammation limited to the distal colon (proctitis or proctosigmoiditis)
Christophi, George P +2 more
core +3 more sources
Oxidative Medicine and Cellular Longevity, 2022 Objective. To systematically assess effectiveness and safety of Bifidobacterium quadruple viable bacteria combined with mesalamine against ulcerative colitis (UC) in the Asian population. Methods.
Fei Xie +7 more
semanticscholar +1 more source
Suppository treatment in ulcerative proctitis
European Journal of Inflammation, 2021 Ulcerative proctitis (UP) is a common form of ulcerative colitis (UC), the number of patients with UP is increasing. Suppository treatment containing mesalamine is usually the first-line choice for mild to moderate UP, here, we review the publications on
Yingjie Si +3 more
doaj +1 more source
Red-Brown Urine Discolouration in Two Patients Taking Mesalamine [PDF]
, 2016 A 38-year-old male and a 36-year-old female experienced red-brown urine discolouration after 2 and 3 days, respectively, during the use of mesalamine for inflammatory bowel disease.
Florence van Hunsel, Tim Smeets
core +1 more source
Medicina, 2022 A 41-year-old man was treated with prednisolone (PSL) and multimatrix (MMX) mesalamine for remission induction therapy of ulcerative colitis. PSL was tapered due to successful remission induction treatment.
Mimari Kanazawa +9 more
doaj +1 more source
Ultrasound-mediated gastrointestinal drug delivery [PDF]
, 2015 available in PMC 2016 April 08There is a significant clinical need for rapid and efficient delivery of drugs directly to the site of diseased tissues for the treatment of gastrointestinal (GI) pathologies, in particular, Crohn’s and ulcerative colitis ...
Anderson, Daniel Griffith +12 more
core +1 more source
Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
Journal of clinical biochemistry and nutrition, 2022 Mesalamine is a key drug in the treatment of ulcerative colitis (UC) for both induction and maintenance therapy. On the other hand, it is known that there are some cases of mesalamine intolerance that are difficult to distinguish from symptoms due to ...
Y. Minagawa +19 more
semanticscholar +1 more source
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study [PDF]
Intestinal Research, 2022 Background/Aims Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC). Long-term use of biologics in developing countries is limited by high cost and frequent side effects.
Ramit Mahajan +12 more
doaj +1 more source
Box-Behnkenov eksperimentalni dizajn u izradi pektin-kompritol ATO 888 obloženih tableta za ciljanu isporuku mesalamina u kolon [PDF]
, 2010 The aim of this study was to investigate the combined influence of 3 independent variables in the compression coated tablet of mesalamine for ulcerative colitis. A 3-factor, 3-level Box-Behnken design was used to derive a second order polynomial equation
JAYVADAN K. PATEL +2 more
core +2 more sources
Global Pediatric Health, 2022 Collagenous gastritis and collagenous colitis are 2 rare gastrointestinal disorders in pediatric patients. Both of these disease processes exist on a clinical spectrum, and are extremely rare to be present together in the pediatric population. Due to the
Ankit Mishra +3 more
semanticscholar +1 more source